[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360474-105":59,"doc-detail-360474-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","enhancing-cisplatin-chemosensitivity-in-gastric-cancer-through-linc00162-silencing-modulation-of-the-pi3kakt-pathway-and-nanog-downregulation","Enhancing cisplatin chemosensitivity in gastric cancer through LINC00162 silencing - Modulation of the PI3K/AKT pathway and NANOG downregulation","","This study investigates how long non-coding RNA LINC00162 (PICSAR) modulates gastric cancer cell sensitivity to cisplatin, and how LINC00162 silencing alters cellular responses under cisplatin-free and cisplatin-combined conditions. Cell viability, IC50 values, apoptosis, sub-G1 cell-cycle arrest, migration, and colony formation were assessed after siRNA-mediated LINC00162 knockdown alone or with cisplatin. qRT-PCR measured pathway-related gene expression including PI3K/AKT components and NANOG, alongside apoptosis and metastasis markers. Results show increased cisplatin sensitivity, higher apoptosis, reduced migration, and impaired colony formation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-cisplatin-chemosensitivity-in-gastric-cancer-through-linc00162-silencing-modulation-of-the-pi3kakt-pathway-and-nanog-downregulation/360474/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-cisplatin-chemosensitivity-in-gastric-cancer-through-linc00162-silencing-modulation-of-the-pi3kakt-pathway-and-nanog-downregulation/360474.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How does LINC00162 silencing affect cisplatin sensitivity in gastric cancer cells?","Question",{"text":112,"@type":113},"LINC00162 silencing increased sensitivity of AGS gastric cancer cells to cisplatin and reduced the cisplatin IC50 from 19.24 µg/mL to 14.08 µg/mL.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular effects were observed after LINC00162 knockdown, especially when combined with cisplatin?",{"text":117,"@type":113},"LINC00162 siRNA induced apoptosis and sub-G1 cell-cycle arrest, with much stronger effects in the combination group (apoptosis 41.7% and Sub-G1 arrest 17.3%) than control or single treatments.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes and pathways were evaluated to explain the mechanism?",{"text":121,"@type":113},"Gene expression involved in the investigated pathways was measured by qRT-PCR, including apoptosis and metastasis markers (BAX, BCL2, TP53, MMP-9, CASP3, CASP9) and signaling/regulatory components (AKT, PI3K, NANOG).",{"name":123,"@type":110,"acceptedAnswer":124},"Does targeting LINC00162 influence migration and colony formation?",{"text":125,"@type":113},"Yes. siRNA-mediated inhibition of LINC00162, either alone or combined with cisplatin, decreased migration and colony formation ability of AGS gastric cancer cells.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},360474,1790188503,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Enhancing cisplatin chemosensitivity in gastric cancer through LINC00162 silencing: Modulation of the PI3K/AKT pathway and NANOG downregulation  \nSeyed Ali Hosseini1 ID , Amir Ali Mokhtarzadeh2* ID , Saeid Ghorbian3* ID , Behzad Baradaran2, Changiz Ahmadizadeh1  \n1Department of Biology, Ah.C., Islamic Azad University, Ahar, Iran 2Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 3Department of Biology, Ta.C., Islamic Azad University, Tabriz, Iran  \nArticle Info  \nArticle Type:  \nOriginal Article  \nArticle History:  \nReceived: 7 Sep. 2025  \nRevised: 30 Dec. 2025  \nAccepted: 21 Feb. 2026  \nePublished: 19 Apr. 2026  \nKeywords:  \nLncRNA Combination therapy Gastric cancer Cisplatin  \nApoptosis Metastasis  \nand drug response. In this study, the potential effect of the long non-coding RNA LINC00162 (PICSAR) on modulating the chemosensitivity of gastric cancer cells to cisplatin was investigated. Furthermore, the impact ofthe LINC00162 silencing on cellular responses was evaluated under two conditions: after the siRNA-mediated silencing ofthe LINC00162 alone, and after combined treatment with cisplatin.  \nMethods: Firstly, the viability of the cells following siRNA-mediated LINC00162 silencing, treatment with cisplatin, and the combination of both was evaluated. Half inhibitory concentration (IC50) of the cisplatin chemotherapy drug was assessed individually and after silencing of the LINC00162 via siRNA. Additionally, we investigated apoptosis, cell cycle arrest, migration, and colony formation in the cancer cells following the combination treatment. Finally, the effect of the combination treatment on the expression of the genes involved in these pathways, including BAX, BCL2, TP53, MMP-9, CASP3, CASP9, AKT, PI3K, and NANOG was evaluated by qRT-PCR.  \nResults: Findings indicated that LINC00162 silencing increased the sensitivity of the AGS gastric cancer cells to cisplatin and reduced the IC50 of cisplatin from 19.24 µg/mL to 14.08 µg/mL. Furthermore, LINC00162 siRNA induced apoptosis, increasing the apoptosis rate to 10.69% compared to 6.19% in the control group, and also caused sub-G1 cell cycle arrest (3.94%). This effect was significantly enhanced in the combination treatment group (apoptosis: 41.7% and Sub-G1 arrest: 17.3%) compared to the control group or either single treatment. Moreover, our study demonstrated that siRNA-mediated inhibition of the LINC00162, both individually and in combination with cisplatin, decreased the migration and colony formation ability ofAGS cancer cells.  \nConclusion: These findings suggest that targeting LINC00162 may potentially enhance the efficacy ofcisplatin in gastric cancer cells and may represent a promising therapeutic strategy for gastric cancer.  \n*Corresponding authors: Amir Ali Mokhtarzadeh, [Email: ahad.mokhtarzadeh@gmail.com](Email: ahad.mokhtarzadeh@gmail.com); Saeid Ghorbian, Email: [saeid.ghorbian@iau.ac.ir](saeid.ghorbian@iau.ac.ir)  \n © 2026 The Author(s) . This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)). Non-commercial uses of the work are permitted, provided the original work is properly cited.  \nIntroduction  \nGastric cancer (GC), a common cancer of the gastrointestinal tract, is one of the most prevalent malignancies around the world. The 2020 GLOBOCAN report outlined GC as the 5th most prevalent cancer (with over one million new cases in 2020) and the 4th leading cause of cancer (769000 deaths in 2020) globally. Eastern Asia (Japan and Mongolia) and Eastern Europe have the highest incidence of GC.1 In recent years, remarkable advances in diagnosing and treating early GC have occurred. Although these advances have greatly improved the treatment of GC, more than half of the patients are still diagnosed at an advanced stage, with a poor prognosis.2 D","cbCaibg3wTz7cyei","https://ap.wps.com/l/cbCaibg3wTz7cyei","pdf",3595924,14,"English","# Introduction\n## Cisplatin resistance and need for combination strategies\n## Role of long noncoding RNAs in cancer\n# Methods\n## Cell viability and IC50 after siRNA and cisplatin\n## Apoptosis, cell-cycle arrest, migration, and colony formation\n## qRT-PCR analysis of pathway and marker genes\n# Results\n## Reduced IC50 and enhanced apoptosis with LINC00162 silencing\n## Cell-cycle arrest, migration inhibition, and reduced colony formation\n## Changes in gene expression via PI3K/AKT and NANOG-related pathways\n# Conclusion","[{\"question\":\"How does LINC00162 silencing affect cisplatin sensitivity in gastric cancer cells?\",\"answer\":\"LINC00162 silencing increased sensitivity of AGS gastric cancer cells to cisplatin and reduced the cisplatin IC50 from 19.24 µg/mL to 14.08 µg/mL.\"},{\"question\":\"What cellular effects were observed after LINC00162 knockdown, especially when combined with cisplatin?\",\"answer\":\"LINC00162 siRNA induced apoptosis and sub-G1 cell-cycle arrest, with much stronger effects in the combination group (apoptosis 41.7% and Sub-G1 arrest 17.3%) than control or single treatments.\"},{\"question\":\"Which genes and pathways were evaluated to explain the mechanism?\",\"answer\":\"Gene expression involved in the investigated pathways was measured by qRT-PCR, including apoptosis and metastasis markers (BAX, BCL2, TP53, MMP-9, CASP3, CASP9) and signaling/regulatory components (AKT, PI3K, NANOG).\"},{\"question\":\"Does targeting LINC00162 influence migration and colony formation?\",\"answer\":\"Yes. siRNA-mediated inhibition of LINC00162, either alone or combined with cisplatin, decreased migration and colony formation ability of AGS gastric cancer cells.\"}]","Enhancing cisplatin chemosensitivity in gastric cancer through LINC00162 silencing - Modulation of the PI3K/AKT pathway and NANOG downregulation | PDF",1790140216,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31268b3866175b4f3adfe11c2e7d2464.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97636878d31b801bf17962fb2c550cdf.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a18c3bd8767f01ab7b7c015beefbc61.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/889baf5ef840af2e68b4d671f5cee296.webp",980,1385]